There’s only one stateside exchange-listed megacap — a stock commanding a market cap north of $300 billion — that has risen by better than 50% this year. Facebook (NASDAQ:FB) has soared 53.5% so far in 2019. To be fair, there are just 14 stocks including Facebook that are currently at megacap status. It’s a thin pool. However, Facebook […]

In the age of low interest rates and technological change, disruptive growth stocks have reigned supreme. Two of the best-performing tech market leaders in the past few years have been Amazon (NASDAQ:AMZN) and Netflix (NASDAQ:NFLX). As you can see, both stocks have absolutely trounced the broader market, nearly quadrupling over the past five years, versus just a 66% gain for […]

Speculators love toiling away in low-priced stocks, but there is an opportunity for more dedicated investors to cash in if they’re willing to do the research. Most stocks trading below $5 are there for a reason, and they’ll probably stay that way. However, sometimes a stock breaks out of Mr. Market’s doghouse. Qutoutiao (NASDAQ:QTT), Trivago (NASDAQ:TRVG), and Fitbit (NYSE:FIT)are some […]

Tesla’s (NASDAQ:TSLA) second-quarter vehicle production and delivery update is out — and investors are impressed based on the stock’s sharp 7% jump in after-hours trading as of 6:40 p.m. EDT Tuesday. Deliveries during the quarter surged to a record high, driven primarily by a huge increase in Model 3 deliveries. The upbeat update on Tesla’s […]

Biotech investing isn’t for the faint of heart. The odds that any particular candidate treatment will be a success are low, and commercializing a drug is hard. However, the returns can be amazing when everything goes according to plan. We asked a team of Motley Fool contributors to share the names of some biotech stocks […]